SPG9A with the new occurrence of an ALDH18A1 mutation in a CMT1A family with PMP22 duplication: case report
Open Access
- 11 February 2021
- journal article
- case report
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-5
Abstract
Background: ALDH18A1 mutations lead to delta-1-pyrroline-5-carboxylate-synthetase (P5CS) deficiency, which is a urea cycle-related disorder including SPG9A, SPG9B, autosomal dominant cutis laxa-3 (ADCL3), and autosomal recessive cutis laxa type 3A (ARCL3A). These diseases exhibit a broad clinical spectrum, which makes the diagnosis of P5CS deficiency difficult. We report here a rare Japanese family including both patients with an ALDH18A1 mutation (SPG9A) and ones with CMT1A. Case presentation: A Japanese family included five patients with the CMT phenotype and five with the HSP phenotype in four generations. The patients with the HSP phenotype showed a pure or complicated form, and intrafamilial clinical variability was noted. Genetically, FISH analysis revealed that two CMT patients had a PMP22 duplication (CMT1A). Exome analysis and Sanger sequencing revealed five HSP patients had an ALDH18A1 heterozygous mutation of c.755G > A, which led to SPG9A. Haplotype analysis revealed that the ALDH18A1 mutation must have newly occurred. To date, although de novo mutations of ALDH18A1 have been described in ADCL3A, they were not mentioned in SPG9A in earlier reports. Thus, this is the first SPG9A family with a de novo mutation or the new occurrence of gonadal mosaicism of ALDH18A1. Analysis of serum amino acid levels revealed that two SPG9A patients and two unaffected family members had low citrulline levels and one had a low level of ornithine. Conclusions: Since the newly occurring ALDH18A1 mutation, c.755G > A, is the same as that in two ADHSP families and one sporadic patient with SPG9A reported previously, this genomic site might easily undergo mutation. The patients with the c.755G > A mutation in our family showed clinical variability of symptoms like in the earlier reported two families and one sporadic patient with this mutation. Further studies are required to clarify the relationship between the amino acid levels and clinical manifestations, which will reveal how P5CS deficiency influences disease phenotypes including ARCL3A, ADCL3, SPG9B, and SPG9A.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP18K07495)
This publication has 17 references indexed in Scilit:
- jMorp: Japanese Multi Omics Reference PanelNucleic Acids Research, 2017
- ALDH18A1-related cutis laxa syndrome with cyclic vomitingBrain and Development, 2016
- Human genetic variation database, a reference database of genetic variations in the Japanese populationJournal of Human Genetics, 2016
- A global reference for human genetic variationNature, 2015
- Recurrent De Novo Mutations Affecting Residue Arg138 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis LaxaThe American Journal of Human Genetics, 2015
- ALDH18A1gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanismBrain, 2015
- Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegiaBrain, 2015
- Allegro version 2Nature Genetics, 2005
- dbSNP: the NCBI database of genetic variationNucleic Acids Research, 2001
- Cataracts, motor system disorder, short stature, learning difficulties, and skeletal abnormalities: A new syndrome?American Journal of Medical Genetics, 1996